Effects of somatostatin and its analogues on tyrosine kinase activity in rodent tumors

NeuroSignals

Volumn 9, Issue 5, 2000, Pages 255-259

  Lachowicz Ochędalska, Agnieszka ^a   Rębas, Elzbieta ^b   Kunert Radek, Jolanta ^a   Winczyk, Katarzyna ^a   Pawlikowski, Marek ^a  

^a Institute of Endocrinology   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cancer; CH 275; Colon; Octreotide; Pituitary; Somatostatin; Tumor; Tyrosine kinases

Indexed keywords

NEUROPEPTIDE; OCTREOTIDE; PROTEIN TYROSINE KINASE; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HYPOPHYSIS TUMOR; MALE; MOUSE; NONHUMAN; PHOSPHORYLATION; RAT; RODENT; TISSUE HOMOGENATE;

ANIMALS; COLONIC NEOPLASMS; HORMONES; MALE; MICE; MICE, INBRED STRAINS; NEOPLASMS, EXPERIMENTAL; OCTREOTIDE; PITUITARY NEOPLASMS; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; SOMATOSTATIN;

EID: 0033803285     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014647     Document Type: Article

References (20)

1. Ulrich A, Schlessinger J: Signal transduction receptor with tyrosine kinase activity. Cell 1990;61:203-212.
2. Marshall CJ: Specificity of receptor tyrosine kinase signalling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
3. Lamberts SWJ, Krenning EP, Reubi JC: The role of somatostatin and its analogues in the diagnosis and treatment of tumors. Endocr Rev 1991; 12:450-482.
4. Reubi JC: Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy. Q J Nucl Med 1997;41(2):63-70.
5. Pawlikowski M, Kunert-Radek J, Stepieii H: Somatostatin-an antiproliferative hormone?; in Dohler KD, Pawlikowski M (eds): Progress in Neuropeptide Research. Birkhau-ser, Basel, 1988, pp 3-12.
6. Schally AV: Oncological applications of somatostatin analogues. Cancer Res 1988;48:6977-6985.
7. Lee MT, Liebow C, Kamer AR, Schally AV: Effects of epidermal growth factor and analogues of luteinizing hormone releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 1991;88: 1656-1660.
8. Pawlikowski M, Lachowicz L, Ku-nert-Radek J, Winczyk K, Janis-zewska G, Szkudlarek J: Differential effects of somatostatin and its analog on protein tyrosine kinase activity in the rat pituitary and murine colonic tumors. Biochem Biophys Res Commun 1998;246:375-377.
9. Liapakis G, Hoeger C, Rivier J, Rei-sine T: Development of a selective agonist at the somatostatin receptor subtype SSTR1. J Pharmacol Exp Ther 1996;276:1089-1094.
10. Hirano AA, Greengard P, Huganir RL: Protein tyrosine kinase activity and its endogenous substrates in rat brain: A subcellular and region survey. J Neurochem 1998;50(5):1447-1455.
11. Ohnishi ST, Barr JKA: A simplified method for quantitating protein using the biuret and phenol reagent. Anal Biochem 1978;86:193-200.
12. Brevini TAL, Bianchi R, Motta M: Effect of somatostatin-14 on the activity of the EGF/TGF system in the human prostatic cancer cell line LNCaP. Abstracts Conf Somatostatin Analogues: Basic and Clinical Perspectives, Sorrento, November 16-19, 1995.
13. Pawlikowski M, Kunert-Radek J, Winczyk K: Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro. Cytobios 1997;89:183-187.
14. James RA, Weightman DR: Somatostatin receptors: Types and classification in the pituitary. Endocrinologist 1995;5:55-60.
15. Schaer JC, Waser B, Mengod G, Reubi JC: Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gas-troentero-pancreatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography. Int J Cancer 1997;70(5):530-537.
16. Pawlikowski M, Kunert-Radek J, Grochal M, Zielinski K, Kulig A: The effect of the somatostatin analog octreotide on diethylstilbestrol-induced prolactin secretion, cell proliferation and vascular changes in the rat anterior pituitary gland. His-tol Histopathol 1997;12:991-994.
17. Pawlikowski M, Kunert-Radek J, Winzyk K: Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro. Cytobios 1997;89:183-187.
18. Meien-Mucha G, Winczyk K, Paw-likowski M: Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer. Anticancer Res 1998; 18:3615-3620.
19. Patel YC, Srikant CB: Subtype selectivity of peptide analogues for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 1994;135:2814-2817.
20. Goldberg RM, Moertel CG, Wie-land HS: A phase III evaluation of somatostatin analog (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. Cancer 1995;76:961-966.